Clinical Trials Browser

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT00771017 2023-05-25

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT04483414 2023-05-19

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Phase EARLY_PHASE1 Withdrawn

Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT05245435 2023-03-20

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Phase NA Withdrawn

Genitourinary

Prostatic Neoplasms

NCT04797078 2023-03-10

FLAPP

Phase NA Withdrawn

Genitourinary

Prostatic Neoplasms

NCT05705700 2023-02-27

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT03987568 2022-12-21

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Phase NA Withdrawn

Genitourinary

Prostatic Neoplasms

NCT03709550 2022-10-05

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

Patient Recall of Cancer Screening and Diagnosis

PROTOMEN

NeoPSMA

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology

REPRESENTATION

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

KATANA E3M

KATANA E6M

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

Prostate MRI and Pylarify PSMA PET/CT

KOALA

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

Using Meditation for Oncology Anxiety

18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

A Yoga Program for Patients Undergoing Prostate Cancer Surgery

LUNAAR

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

TRACK

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

ARTGU

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

HIIT PCa

A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery

SMMART Adaptive Clinical Treatment (ACT) Trial

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

URODETECT-WP2

A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

CARE

Pioglitazone and Insulin Resistance in ADT

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Insulin Resistance and Androgen Deprivation Therapy

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Insulin Resistance Following ADT for Prostate CA

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

FLAPP

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer